Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Dissolution Media Filtering and Degassing – V 2.0

Posted on By

Analytical Method Development: SOP for Dissolution Media Filtering and Degassing – V 2.0

Standard Operating Procedure for Filtering and Degassing Dissolution Media in AMD


Department Analytical Method Development
SOP No. SOP/AMD/214/2025
Supersedes SOP/AMD/214/2022
Page No. Page 1 of 12
Issue Date 21/05/2025
Effective Date 23/05/2025
Review Date 21/05/2026

1. Purpose

This SOP provides a standardized procedure for filtering and degassing dissolution media to remove particulate matter and dissolved gases that may interfere with dissolution testing results. Proper preparation of media is

critical to ensure reproducibility and regulatory compliance during dissolution testing.

2. Scope

This SOP applies to all dissolution media prepared and used within the Analytical Method Development (AMD) department for dissolution testing of pharmaceutical solid oral dosage forms.

3. Responsibilities

  • Analytical Chemist: Responsible for preparation, filtration, degassing, and documentation of dissolution media.
  • Lab Assistant: Assists in washing and setting up filtration and degassing equipment.
  • QA Executive: Verifies the integrity and suitability of equipment and process compliance.
See also  Analytical Method Development: Zeta Potential Determination SOP - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring adherence to this SOP during dissolution media preparation to maintain testing consistency and compliance.

5. Procedure

5.1 Media Preparation

  1. Prepare required volume of dissolution medium (e.g., 0.1N HCl, acetate buffer pH 4.5, phosphate buffer pH 6.8, water, etc.) according to the relevant dissolution method.
  2. Use calibrated pH meter to confirm media pH.
  3. Label containers with media type, volume, preparation date, expiry date, and initials.

5.2 Filtration Procedure

  1. Use a validated vacuum filtration unit equipped with:
    • 0.45 µm membrane filter (nylon, PVDF, or equivalent)
    • Glass filter holders and clean receiving flask
  2. Assemble the filtration system on a clean, vibration-free bench or laminar airflow unit.
  3. Pre-rinse the filter membrane with 50 mL of dissolution media before filtration.
  4. Filter the media in batches not exceeding 5 L at a time to prevent overpressure or leakage.
  5. Transfer filtered media into clean, labeled storage carboys or vessels.

5.3 Degassing Methods

Choose any one of the following degassing methods depending on method validation requirements:

  1. Vacuum Degassing:
    • Apply vacuum at 300–500 mmHg for 5–10 minutes under gentle stirring.
    • Use vacuum desiccator or degassing assembly with stir bar.
  2. Helium Sparging:
    • Sparge media with helium gas at low flow rate (~100 mL/min) for 10–15 minutes.
    • Use only approved helium gas cylinder with regulator.
  3. Ultrasonication:
    • Place media container in ultrasonic bath for 15–20 minutes.
    • Ensure consistent bath temperature and no bubble formation post-sonication.
See also  Analytical Method Development: SOP for Ion Chromatography Method Development - V 2.0

5.4 Storage and Handling

  1. Use filtered and degassed media on the same day of preparation.
  2. Store media at 20–25°C and avoid exposure to sunlight and dust.
  3. If media is not used within 24 hours, discard and re-prepare fresh medium.

5.5 Documentation

  1. Enter preparation details in Annexure-1: Dissolution Media Preparation Log.
  2. Record degassing method, equipment ID, and any deviations in Annexure-2.
  3. QA to verify record during batch review or inspection.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • PVDF: Polyvinylidene Fluoride
  • µm: Micrometer

7. Documents

  1. Dissolution Media Preparation Log – Annexure-1
  2. Degassing Method and Equipment Record – Annexure-2
  3. Filter Integrity Checklist – Annexure-3
See also  Analytical Method Development: Sample Handling in Microbiological Testing - V 2.0

8. References

  • USP General Chapter <711>: Dissolution
  • FDA Guidance: Dissolution Testing for Immediate Release Solid Oral Dosage Forms
  • ICH Q6A: Specifications – Test Procedures and Acceptance Criteria

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Namrata Kulkarni Devendra Patil Sunita Reddy
Designation Analyst QA Reviewer Head – AMD
Department Analytical Method Development QA Analytical Method Development

11. Annexures

Annexure-1: Dissolution Media Preparation Log

Date Media Type pH Volume Prepared By QA Verified
21/05/2025 Phosphate Buffer 6.8 9000 mL Namrata K. Devendra P.

Annexure-2: Degassing Record

Date Method Equipment ID Duration Performed By
21/05/2025 Vacuum DG/VAC/01 10 min Namrata K.

Annexure-3: Filter Integrity Checklist

Date Filter Type Integrity Test Result Remarks
21/05/2025 0.45 µm PVDF Pass Rinsed prior to use

Revision History:

Revision Date Revision No. Details Reason Approved By
21/05/2025 2.0 Included additional degassing options and annexures Annual SOP Review Sunita Reddy
12/05/2022 1.0 Initial Release New SOP QA Head
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Sterile Injectable Manufacturing: SOP for Filtration Integrity Testing before Sterile Filling – V 2.0
Next Post: Biosimilars: SOP for Strong Cation Exchange Chromatography – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version